Table 3.

Functional Pathways Identified Both in the Analysis of the Predicted Targets of miRNAs in Exosomes that Were Less in Syndecan-1–Deficient Conditions and in the Analysis of Genes Up-Regulated in Adenocarcinoma Samples

KEGG pathway	FDR
Cell cycle	9.64 × 10−19
p53 signaling pathway	7.87 × 10−6
Oocyte meiosis	1.19 × 10−5
Bladder cancer	5.24 × 10−5
RNA transport	1 × 10−4
Melanoma	1.8 × 10−3
Glioma	2.8 × 10−3
Pancreatic cancer	5.1 × 10−3
Prostate cancer	1.2 × 10−2
Chronic myeloid leukemia	1.7 × 10−2
Non–small cell lung cancer	1.8 × 10−2
ErbB-signaling pathway	2.2 × 10−2
Neurotrophin-signaling pathway	3.2 × 10−2
Endometrial cancer	3.7 × 10−2
Lysine degradation	4.5 × 10−2

ErbB, epidermal growth factor receptor; FDR, false discovery rate; KEGG, Kyoto Encyclopedia of Genes and Genomes.